Impact of psychosocial status on liver transplant process

Ann Hepatol. 2019 Nov-Dec;18(6):804-809. doi: 10.1016/j.aohep.2019.06.011. Epub 2019 Aug 20.

Abstract

Liver transplant candidates and recipients are at high risk of psychological distress. Social, psychological and psychiatric patterns seem to influence morbidity and mortality of patients before and after transplant. An accurate organ allocation is mandatory to guarantee an optimal graft and recipient survival. In this context, the pre-transplant social, psychological and psychiatric selection of potential candidates is essential for excluding major psychiatric illness and for estimating the patient compliance. Depression is one of the most studied psychological conditions in the field of organ transplantation. Notably, an ineffectively treated depression in the pre-transplant period has been associated to a worst long-term recipient survival. After transplant, personalized psychological intervention might favor recovery process, improvement of quality of life and immunosuppressant adherence. Active coping strategy represents one of the most encouraging ways to positively influence the clinical course of transplanted patients. In conclusion, multidisciplinary team should act in three directions: prevention of mood distress, early diagnosis and effective treatment. Active coping, social support and multidisciplinary approach might improve the clinical outcome of transplanted patients.

Keywords: Compliance; Multidisciplinary team; Psychological status; Social support.

Publication types

  • Review

MeSH terms

  • Adaptation, Psychological
  • Depressive Disorder / psychology
  • Graft Rejection / prevention & control
  • Graft Survival
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Liver Transplantation*
  • Medication Adherence / psychology
  • Mental Health
  • Patient Care Team
  • Patient Selection*
  • Psychological Distress*
  • Psychology
  • Quality of Life
  • Social Support*
  • Survival Rate
  • Transplant Recipients / psychology*

Substances

  • Immunosuppressive Agents